Related Experiment Videos
Essential hypertension and insulin resistance
R Dzúrik1, J Málková, V Spustová
1Centre of Clinical Pharmacology, Institute of Preventive and Clinical Medicine, Bratislava, Czechoslovakia.
Insights
Insulin resistance (IR) is a key risk factor for hypertension and atherosclerosis, affecting metabolism. Diagnosis involves glucose tolerance tests, but treatment remains challenging, though research shows promise.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Disease Research
Background:
- Insulin resistance (IR) is linked to hypertension and atherosclerosis.
- IR is also prevalent in obesity, dyslipidaemia, and type 2 diabetes.
- It can be observed in untreated hypertension and in children of hypertensive parents.
Purpose of the Study:
- To explore the role of insulin resistance in hypertension and atherosclerosis.
- To discuss diagnostic methods for insulin resistance.
- To review current treatment strategies and future research directions.
Main Methods:
- Diagnosis of IR through insulin and glycaemia measurements during a glucose tolerance test.
- Review of existing literature on IR, hypertension, and related metabolic disorders.
Main Results:
- Insulin resistance alters carbohydrate, lipid, and protein metabolism.
- IR is implicated in the development of hypertension.
- Differential diagnosis is crucial as IR is not exclusive to hypertension.
Conclusions:
- Insulin resistance is a significant risk factor for cardiovascular conditions.
- Current pharmacological treatments for IR are limited, with non-pharmacological measures being primary.
- Emerging research offers promising avenues for future therapeutic interventions.
Abstract:
Insulin resistance (IR) appears to be an important risk factor of both hypertension and atherosclerosis. Moreover, it is present also in obesity, dyslipoproteinaemia and non-insulin dependent diabetes. IR could be found in untreated hypertension and even in normotensive children of hypertensive parents. It alters carbohydrate, lipid and protein metabolism and participates directly in the development of hypertension. The diagnosis of IR is possible by simple determination of insulin and glyceamia during glucose tolerance test. The differential diagnosis is obligatory because IR is not specific just for hypertension. Treatment, with the exception of nonpharmacological measures, is unsatisfactory. However, results of newest research are highly promising.